| Glaxosmithkline PLC10% owner · 3 transactions | — | 9.64Mas of Mar 2016 | — | 1.35M | — |
| Samaha Eli10% owner · 3 transactions | — | 9.51Mas of Aug 2024 | — | 2.50M | — |
| Winningham Rick ECHIEF EXECUTIVE OFFICER, Director · 72 transactions | — | 1.73M† | 2.40M | 90.0K | 50.0K |
| Pasqualone FrankSVP, CHIEF BUSINESS OFFICER · 32 transactions | — | 429.8Kas of Nov 2021 | 568.0K | 4.0K | — |
| Hindman Andrew A.SVP, CHIEF FINANCIAL OFFICER · 18 transactions | — | 384.7Kas of Nov 2022 | 558.5K | — | 65.0K |
| Pitzer Kenneth RSVP, PROD STRAT & COMM PLNG · 34 transactions | — | 380.1Kas of Feb 2022 | 505.0K | — | — |
| Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY · 19 transactions | — | 355.2K | 287.5K | — | — |
| Sawaf AzizSVP & CHIEF FINANCIAL OFFICER · 19 transactions | — | 336.8K | 292.5K | — | — |
| Worboys Philip DSVP, RESEARCH & TRANSL SCIENCE · 36 transactions | — | 330.8Kas of Nov 2021 | 453.0K | — | 36.6K |
| Graham Richard ASVP, RESEARCH & DEVELOPMENT · 35 transactions | — | 314.9Kas of Feb 2024 | 422.5K | — | 53.3K |
| Mammen MathaiSVP, Research & Development · 9 transactions | — | 288.1Kas of Mar 2016 | 220.0K | — | — |
| Shafer Bradford JEVP, Gen. Counsel, Secretary · 50 transactions | — | 277.8Kas of Aug 2021 | 583.0K | — | 143.1K |
| Hegde Sharathchandra SSVP, Research · 22 transactions | — | 259.9Kas of Aug 2019 | 269.0K | — | 9.0K |
| Whitesides George MDirector · 9 transactions | — | 249.1K†as of Apr 2021 | 51.0K | 4.0K | — |
| Haumann Brett KChief Medical Officer · 36 transactions | — | 242.5Kas of Feb 2021 | 508.0K | — | 53.0K |
| Sabesan VijaySVP, TECHNICAL OPERATIONS · 15 transactions | — | 235.5Kas of Nov 2021 | 130.0K | — | 1.0K |
| Lee JunningSr. VP, Technical Operations · 13 transactions | — | 234.1K†as of Feb 2017 | 200.0K | 9.0K | — |
| Farnum RhondaSVP, COMM & MEDICAL AFFAIRS · 49 transactions | — | 226.8K | 239.0K | — | 139.1K |
| Miller AineSVP, DEV & HEAD OF IRE OFFICE · 15 transactions | — | 189.8K | 141.7K | — | — |
| Blum Leonard MSr VP, Chief Comm. Officer · 6 transactions | — | 182.7Kas of Feb 2016 | 90.0K | — | — |
| Gala Renee DSVP, Chief Financial Officer · 24 transactions | — | 157.7Kas of Nov 2018 | 276.8K | 10.0K | 53.7K |
| Malkiel Burton GDirector · 13 transactions | — | 115.6K†as of May 2023 | 70.0K | 41.0K | — |
| Brady AnnPRESIDENT, TBIL · 15 transactions | — | 110.3Kas of Feb 2022 | 80.0K | — | — |
| Mitchell Dean JDirector · 12 transactions | — | 97.2K | 97.2K | — | — |
| Suliman ShehnaazSVP, Corp Dev & Strategy · 5 transactions | — | 97.2Kas of Feb 2019 | 110.0K | — | — |
| Smaldone Alsup LaurieDirector · 10 transactions | — | 81.0K | 81.0K | — | — |
| O'Connor DonalDirector · 15 transactions | — | 80.2K | 94.2K | — | 4.0K |
| Gunderson Robert V JRDirector · 7 transactions | — | 78.9K†as of Apr 2021 | 51.0K | — | — |
| Young William DDirector · 8 transactions | — | 78.0Kas of Apr 2022 | 60.9K | — | — |
| Pakianathan DeepikaDirector · 7 transactions | — | 64.1K | 64.1K | — | — |
| Broshy EranDirector · 16 transactions | — | 60.2K | 91.2K | — | 74.5K |
| Molineaux SusanDirector · 7 transactions | — | 51.0K†as of Apr 2021 | 51.0K | — | — |
| Gray SusannahDirector · 6 transactions | — | 48.1K | 48.1K | — | — |
| Ringrose Peter SDirector · 5 transactions | — | 38.0Kas of Apr 2019 | 34.6K | — | — |
| Grant Jeremy TDirector · 4 transactions | — | 33.0Kas of May 2025 | 33.0K | — | — |
| Fore HenriettaDirector · 4 transactions | — | 24.0Kas of Aug 2017 | 18.0K | 6.0K | — |
| GSK plcFormer 10% Owner · 1 transaction | — | 0as of Sep 2022 | — | — | — |
| Theravance Inc10% owner · 1 transaction | — | 0as of May 2014 | — | — | — |